You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapsed SCLC

Showing 1 - 25 of 5,794
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small-cell Lung Cancer, Relapsed Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer Trial in Kissimmee, Tampa (Nivolumab,

Recruiting
  • Small-cell Lung Cancer
  • +2 more
  • Kissimmee, Florida
  • +1 more
Nov 2, 2022

Small Cell Lung Cancer Trial (SC0245, Irinotecan)

Not yet recruiting
  • Small Cell Lung Cancer
  • (no location specified)
Feb 7, 2023

Small Cell Lung Cancer (SCLC) Trial (Tarlatamab, Lurbinectedin, Topotecan)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • (no location specified)
Feb 21, 2023

Small-cell Lung Cancer, Neuroendocrine Carcinoma Trial (Iadademstat, Paclitaxel)

Not yet recruiting
  • Small-cell Lung Cancer
  • Neuroendocrine Carcinoma
  • (no location specified)
Jun 13, 2022

Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)

Not yet recruiting
  • Relapsed Small Cell Lung Cancer
  • Irinotecan hydrochloride liposome Injection
  • Topotecan
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Nov 7, 2023

SCLC, Recurrent Trial in Seoul (Durvalumab+AZD2811 to SCLC patients)

Terminated
  • SCLC, Recurrent
  • Durvalumab+AZD2811 to SCLC patients
  • Seoul, Gangnam-gu, Korea, Republic of
    Samsung Medical Center
Feb 8, 2022

SCLC, Extensive Stage Trial in Tianjin (DLL3-CAR-NK cells)

Recruiting
  • SCLC, Extensive Stage
  • DLL3-CAR-NK cells
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Aug 18, 2022

Lung Cancer Trial in Korea, Republic of (Olaparib+Bevacizumab to SCLC patients)

Recruiting
  • Lung Cancer
  • Olaparib+Bevacizumab to SCLC patients
  • Seoul, Gangnam-gu, Korea, Republic of
  • +3 more
Nov 9, 2022

SCLC Trial in United States (Nivatrotamab)

Terminated
  • SCLC
  • Tampa, Florida
  • +6 more
Jul 11, 2022

Small Cell Lung Cancer Trial in Worldwide (BMS-986012 (anti-fucosyl-GM1), Nivolumab)

Active, not recruiting
  • Small Cell Lung Cancer
  • BMS-986012 (anti-fucosyl-GM1)
  • Nivolumab
  • New York, New York
  • +15 more
Sep 28, 2022

Small Cell Lung Cancer Trial in Tampa, Houston (AMG 119)

Suspended
  • Small Cell Lung Cancer
  • AMG 119
  • Tampa, Florida
  • +1 more
Nov 29, 2021

Relapsed Small Cell Lung Cancer, Refractory Small Cell Lung Carcinoma Trial (Venetoclax 50 MG, Venetoclax 100 MG, Venetoclax 200

Withdrawn
  • Relapsed Small Cell Lung Cancer
  • Refractory Small Cell Lung Carcinoma
  • Venetoclax 50 MG
  • +6 more
  • (no location specified)
Mar 1, 2021

Small Cell Lung Cancer Trial in Shanghai (Irinotecan, Simvastatin)

Not yet recruiting
  • Small Cell Lung Cancer
  • Shanghai, Shanghai, China
  • +1 more
Aug 6, 2021

Small Cell Lung Cancer Trial in Shanghai (Albumin Paclitaxel, Simvastatin)

Recruiting
  • Small Cell Lung Cancer
  • Shanghai, Shanghai, China
  • +1 more
Jul 26, 2021

Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL), Castration Resistant Prostate Cancer (CRPC) Trial in Russian

Recruiting
  • Small Cell Lung Cancer (SCLC)
  • +2 more
  • Tucson, Arizona
  • +62 more
Jan 18, 2023

Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Augusta (Nivolumab 10 MG/ML Intravenous Solution [OPDIVO], Irinotecan

Recruiting
  • Small-cell Lung Cancer
  • Small Cell Lung Carcinoma
  • Nivolumab 10 MG/ML Intravenous Solution [OPDIVO]
  • Irinotecan Injection [Camptosar]
  • Augusta, Georgia
    Georgia Cancer Center at AU Medical Center
Jul 31, 2021

Small Cell Lung Cancer (SCLC) Trial in Iowa City (Nab-paclitaxel, Gemcitabine)

Active, not recruiting
  • Small Cell Lung Cancer (SCLC)
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Jun 4, 2021

Small-cell Lung Cancer Trial in Worldwide (Berzosertib, Topotecan)

Active, not recruiting
  • Small-cell Lung Cancer
  • Santa Rosa, California
  • +47 more
Jun 24, 2022

SCLC Trial in Seoul (AZD6738, Olaparib)

Completed
  • SCLC
  • Seoul, Korea, Republic of
    Samsung Medical Center
Feb 16, 2021

Metastatic Malignant Solid Tumor, Recurrent Lung Small Cell Carcinoma, Recurrent Malignant Solid Tumor Trial in United States

Terminated
  • Metastatic Malignant Solid Neoplasm
  • +8 more
  • Los Angeles, California
  • +13 more
Oct 7, 2022

Small-cell Lung Cancer, Small Cell Lung Carcinoma, Small Cell Lung Cancer Extensive Stage Trial in Worldwide (KRT-232)

Recruiting
  • Small-cell Lung Cancer
  • +3 more
  • Fort Myers, Florida
  • +29 more
Jun 15, 2022

Small Cell Lung Cancer Trial in Seoul (Durvalumab)

Active, not recruiting
  • Small Cell Lung Cancer
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +1 more
Nov 6, 2022

Small Cell Lung Carcinoma Trial in Barcelona, Madrid (Lurbinectedin, Pembrolizumab)

Recruiting
  • Small Cell Lung Carcinoma
  • Barcelona, Spain
  • +4 more
Aug 12, 2022

Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Pittsburgh (Onvansertib)

Recruiting
  • Small-cell Lung Cancer
  • Small Cell Lung Carcinoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 29, 2022

Gastric Cancer, Small-cell Lung Cancer Trial in China, Korea, Republic of, Taiwan (EP0057, Olaparib tablets)

Not yet recruiting
  • Gastric Cancer
  • Small-cell Lung Cancer
  • Shanghai, Changning District, 交通大学 邮政编码, China
  • +20 more
Nov 1, 2022